Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market, Global Outlook and Forecast 2022-2028
ITP (idiopathic thrombocytopenic purpura) is a rare disease with low affliction rates. This disease leads to excessive bruising or bleeding due to the lack of blood platelets. It is also known as immune thrombocytopenia and can affect children and adults alike.
This report contains market size and forecasts of Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics in Global, including the following market information:
Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics market was valued at 446 million in 2021 and is projected to reach US$ 554.1 million by 2028, at a CAGR of 3.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Corticosteroids Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics include Roch, Amgen Inc, Grifols Biologicals Inc. and GlaxoSmithKline Plc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Segment Percentages, by Type, 2021 (%)
Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Segment Percentages, by Application, 2021 (%)
Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics in Global, including the following market information:
Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics market was valued at 446 million in 2021 and is projected to reach US$ 554.1 million by 2028, at a CAGR of 3.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Corticosteroids Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics include Roch, Amgen Inc, Grifols Biologicals Inc. and GlaxoSmithKline Plc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Segment Percentages, by Type, 2021 (%)
- Corticosteroids
- Intravenous Immunoglobulin (IVIG)
- Anti-D Immunoglobulin
- Thrombopoietin Receptor Agonists (TPO-RA)
- Others
Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Segment Percentages, by Application, 2021 (%)
- Hospitals
- Clinics
- Others
Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Roch
- Amgen Inc
- Grifols Biologicals Inc.
- GlaxoSmithKline Plc
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP) THERAPEUTICS OVERALL MARKET SIZE
2.1 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size: 2021 VS 2028
2.2 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Players in Global Market
3.2 Top Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Companies Ranked by Revenue
3.3 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Markets, 2021 & 2028
4.1.2 Corticosteroids
4.1.3 Intravenous Immunoglobulin (IVIG)
4.1.4 Anti-D Immunoglobulin
4.1.5 Thrombopoietin Receptor Agonists (TPO-RA)
4.1.6 Others
4.2 By Type - Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, 2017-2022
4.2.2 By Type - Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, 2023-2028
4.2.3 By Type - Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, 2017-2022
5.2.2 By Application - Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, 2023-2028
5.2.3 By Application - Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, 2017-2022
6.2.2 By Region - Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, 2023-2028
6.2.3 By Region - Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, 2017-2028
6.3.2 US Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size, 2017-2028
6.3.3 Canada Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size, 2017-2028
6.3.4 Mexico Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, 2017-2028
6.4.2 Germany Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size, 2017-2028
6.4.3 France Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size, 2017-2028
6.4.4 U.K. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size, 2017-2028
6.4.5 Italy Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size, 2017-2028
6.4.6 Russia Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size, 2017-2028
6.4.7 Nordic Countries Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size, 2017-2028
6.4.8 Benelux Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, 2017-2028
6.5.2 China Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size, 2017-2028
6.5.3 Japan Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size, 2017-2028
6.5.4 South Korea Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size, 2017-2028
6.5.5 Southeast Asia Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size, 2017-2028
6.5.6 India Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, 2017-2028
6.6.2 Brazil Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size, 2017-2028
6.6.3 Argentina Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, 2017-2028
6.7.2 Turkey Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size, 2017-2028
6.7.3 Israel Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size, 2017-2028
6.7.4 Saudi Arabia Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size, 2017-2028
6.7.5 UAE Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Roch
7.1.1 Roch Corporate Summary
7.1.2 Roch Business Overview
7.1.3 Roch Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Major Product Offerings
7.1.4 Roch Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue in Global Market (2017-2022)
7.1.5 Roch Key News
7.2 Amgen Inc
7.2.1 Amgen Inc Corporate Summary
7.2.2 Amgen Inc Business Overview
7.2.3 Amgen Inc Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Major Product Offerings
7.2.4 Amgen Inc Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue in Global Market (2017-2022)
7.2.5 Amgen Inc Key News
7.3 Grifols Biologicals Inc.
7.3.1 Grifols Biologicals Inc. Corporate Summary
7.3.2 Grifols Biologicals Inc. Business Overview
7.3.3 Grifols Biologicals Inc. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Major Product Offerings
7.3.4 Grifols Biologicals Inc. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue in Global Market (2017-2022)
7.3.5 Grifols Biologicals Inc. Key News
7.4 GlaxoSmithKline Plc
7.4.1 GlaxoSmithKline Plc Corporate Summary
7.4.2 GlaxoSmithKline Plc Business Overview
7.4.3 GlaxoSmithKline Plc Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Major Product Offerings
7.4.4 GlaxoSmithKline Plc Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue in Global Market (2017-2022)
7.4.5 GlaxoSmithKline Plc Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
1.1 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP) THERAPEUTICS OVERALL MARKET SIZE
2.1 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size: 2021 VS 2028
2.2 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Players in Global Market
3.2 Top Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Companies Ranked by Revenue
3.3 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Markets, 2021 & 2028
4.1.2 Corticosteroids
4.1.3 Intravenous Immunoglobulin (IVIG)
4.1.4 Anti-D Immunoglobulin
4.1.5 Thrombopoietin Receptor Agonists (TPO-RA)
4.1.6 Others
4.2 By Type - Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, 2017-2022
4.2.2 By Type - Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, 2023-2028
4.2.3 By Type - Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, 2017-2022
5.2.2 By Application - Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, 2023-2028
5.2.3 By Application - Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, 2017-2022
6.2.2 By Region - Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, 2023-2028
6.2.3 By Region - Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, 2017-2028
6.3.2 US Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size, 2017-2028
6.3.3 Canada Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size, 2017-2028
6.3.4 Mexico Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, 2017-2028
6.4.2 Germany Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size, 2017-2028
6.4.3 France Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size, 2017-2028
6.4.4 U.K. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size, 2017-2028
6.4.5 Italy Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size, 2017-2028
6.4.6 Russia Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size, 2017-2028
6.4.7 Nordic Countries Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size, 2017-2028
6.4.8 Benelux Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, 2017-2028
6.5.2 China Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size, 2017-2028
6.5.3 Japan Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size, 2017-2028
6.5.4 South Korea Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size, 2017-2028
6.5.5 Southeast Asia Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size, 2017-2028
6.5.6 India Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, 2017-2028
6.6.2 Brazil Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size, 2017-2028
6.6.3 Argentina Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, 2017-2028
6.7.2 Turkey Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size, 2017-2028
6.7.3 Israel Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size, 2017-2028
6.7.4 Saudi Arabia Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size, 2017-2028
6.7.5 UAE Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Roch
7.1.1 Roch Corporate Summary
7.1.2 Roch Business Overview
7.1.3 Roch Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Major Product Offerings
7.1.4 Roch Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue in Global Market (2017-2022)
7.1.5 Roch Key News
7.2 Amgen Inc
7.2.1 Amgen Inc Corporate Summary
7.2.2 Amgen Inc Business Overview
7.2.3 Amgen Inc Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Major Product Offerings
7.2.4 Amgen Inc Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue in Global Market (2017-2022)
7.2.5 Amgen Inc Key News
7.3 Grifols Biologicals Inc.
7.3.1 Grifols Biologicals Inc. Corporate Summary
7.3.2 Grifols Biologicals Inc. Business Overview
7.3.3 Grifols Biologicals Inc. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Major Product Offerings
7.3.4 Grifols Biologicals Inc. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue in Global Market (2017-2022)
7.3.5 Grifols Biologicals Inc. Key News
7.4 GlaxoSmithKline Plc
7.4.1 GlaxoSmithKline Plc Corporate Summary
7.4.2 GlaxoSmithKline Plc Business Overview
7.4.3 GlaxoSmithKline Plc Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Major Product Offerings
7.4.4 GlaxoSmithKline Plc Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue in Global Market (2017-2022)
7.4.5 GlaxoSmithKline Plc Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES
Table 1. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Opportunities & Trends in Global Market
Table 2. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Drivers in Global Market
Table 3. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Restraints in Global Market
Table 4. Key Players of Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics in Global Market
Table 5. Top Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Product Type
Table 9. List of Global Tier 1 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Roch Corporate Summary
Table 31. Roch Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Product Offerings
Table 32. Roch Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Amgen Inc Corporate Summary
Table 34. Amgen Inc Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Product Offerings
Table 35. Amgen Inc Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Grifols Biologicals Inc. Corporate Summary
Table 37. Grifols Biologicals Inc. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Product Offerings
Table 38. Grifols Biologicals Inc. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. GlaxoSmithKline Plc Corporate Summary
Table 40. GlaxoSmithKline Plc Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Product Offerings
Table 41. GlaxoSmithKline Plc Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue (US$, Mn), (2017-2022)
Table 1. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Opportunities & Trends in Global Market
Table 2. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Drivers in Global Market
Table 3. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Restraints in Global Market
Table 4. Key Players of Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics in Global Market
Table 5. Top Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Product Type
Table 9. List of Global Tier 1 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Roch Corporate Summary
Table 31. Roch Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Product Offerings
Table 32. Roch Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Amgen Inc Corporate Summary
Table 34. Amgen Inc Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Product Offerings
Table 35. Amgen Inc Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Grifols Biologicals Inc. Corporate Summary
Table 37. Grifols Biologicals Inc. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Product Offerings
Table 38. Grifols Biologicals Inc. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. GlaxoSmithKline Plc Corporate Summary
Table 40. GlaxoSmithKline Plc Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Product Offerings
Table 41. GlaxoSmithKline Plc Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue (US$, Mn), (2017-2022)
LIST OF FIGURES
Figure 1. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Segment by Type in 2021
Figure 2. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Segment by Application in 2021
Figure 3. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue in 2021
Figure 8. By Type - Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Roch Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Amgen Inc Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Grifols Biologicals Inc. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. GlaxoSmithKline Plc Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 1. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Segment by Type in 2021
Figure 2. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Segment by Application in 2021
Figure 3. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue in 2021
Figure 8. By Type - Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Roch Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Amgen Inc Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Grifols Biologicals Inc. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. GlaxoSmithKline Plc Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
